ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, is unveiling the new Precision Allograft Cartilage Kit (PACK) at the American Orthopaedic Society for Sports Medicine (AOSSM) annual meeting in Seattle this week. PACK, the company’s new instrumentation set for osteochondral allograft resurfacing, is designed to improve precision and minimize trauma to the cartilage with its optimized and simplified surgical technique.
PACK’s enhanced design provides a more uniform cartilage contact surface and aids in achieving a more precise fit of the allograft into the recipient’s socket. The newly-designed cutters provide a clean recipient socket and allograft plug, creating a line-to-line fit that results in a consistent tight press fit, minimizing the need for additional fixation. In addition, the kit’s innovative coring station articulates to several different angles, accommodating surgeon preference when coring the plug from the allograft – a feature not seen with any other cartilage instrumentation set.
“We are very excited to preview the new PACK during the AOSSM meeting,” said Brian K. Hutchison, president and chief executive officer of RTI Surgical. “The simplified technique offered by this new instrumentation will allow surgeons to approach cartilage restoration with more precision and focus on the end result of improving patient outcomes.”
PACK Precision Allograft Cartilage Kit will be previewed at the RTI Surgical exhibit at booth 300/302 during the AOSSM meeting with an anticipated market launch later this summer. To learn more about RTI Surgical and PACK, please visit RTI’s booth at AOSSM or contact your local RTI Surgical representative.
About RTI Surgical Inc.
RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit http://www.rtix.com/.
Forward Looking Statement
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management’s beliefs and certain assumptions made by our management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, except for historical information, any statements made in this communication about growth rates, new product introductions, future operational improvements and results or regulatory actions or approvals or changes to agreements with distributors also are forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). In addition, these statements are subject to risks associated with the Pioneer’s financial condition, business and operations and the integration of Pioneer’s business with ours. Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting RTI’s website at www.rtix.com or the SEC’s website at www.sec.gov.
